Charity G. Patterson

TL;DR: The transition from acute to chronic low back pain (LBP) is highly prevalent, with a presumed favorable prognosis; however, once chronic, LBP becomes a disabling and expensive condition, and it is unknown whether a standardized prognostic tool (i.e., Subgroups for Targeted Treatment Back tool [SBT]) can estimate this transition or whether early non-guideline concordant treatment is associated with the transition as discussed by the authors.

TL;DR: This randomized clinical trial compares the effectiveness of medical care, group exercise, and manual therapy/individualized exercise in patients with lumbar spinal stenosis.

TL;DR: In this article, a pragmatic, cluster randomized trial using 77 primary care clinics in four health care systems across the United States was conducted to test if implementation of a risk-stratified approach to care would result in lower rates of chronic LBP and improved self-reported disability.

TL;DR: A post-hoc analysis of the HALT PKD trials does not demonstrate a benefit of statin therapy, and a larger randomized trial in young people with ADPKD is necessary to answer the question whether statins can slow renal cyst growth and preserve kidney function.

TL;DR: The discordance between the 6 MWT with the ALSFRS-R and percent predicted FVC in stage II ambulatory patients with ALS indicates that the 6MWT is an independent measure of ambulatory function in both stages of ambulation.